Brenda Libby Coleman

Array ( [id] => 5716317 [patent_doc_number] => 20060079680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Pyrazoloazepine compounds as pharmaceutical agents' [patent_app_type] => utility [patent_app_number] => 10/531111 [patent_app_country] => US [patent_app_date] => 2003-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11728 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079680.pdf [firstpage_image] =>[orig_patent_app_number] => 10531111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674627 [patent_doc_number] => 20040127491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Novel diazabicyclic biaryl derivatives' [patent_app_type] => new [patent_app_number] => 10/703556 [patent_app_country] => US [patent_app_date] => 2003-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9550 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127491.pdf [firstpage_image] =>[orig_patent_app_number] => 10703556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 750142 [patent_doc_number] => 07022717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => 'Chemokine receptor binding heterocyclic compounds' [patent_app_type] => utility [patent_app_number] => 10/703781 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 10 [patent_no_of_words] => 19020 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022717.pdf [firstpage_image] =>[orig_patent_app_number] => 10703781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310612 [patent_doc_number] => 20040142945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Fused heterocyclic compounds and use thereof' [patent_app_type] => new [patent_app_number] => 10/702295 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31759 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142945.pdf [firstpage_image] =>[orig_patent_app_number] => 10702295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 510797 [patent_doc_number] => 07196101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-27 [patent_title] => 'Bis(5-aryl-2-pyridyl) derivatives' [patent_app_type] => utility [patent_app_number] => 10/690671 [patent_app_country] => US [patent_app_date] => 2003-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20665 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/196/07196101.pdf [firstpage_image] =>[orig_patent_app_number] => 10690671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 813774 [patent_doc_number] => 07414047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-19 [patent_title] => 'Piperazinyl and diazapanyl benzamides and benzthioamides' [patent_app_type] => utility [patent_app_number] => 10/690115 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18246 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/414/07414047.pdf [firstpage_image] =>[orig_patent_app_number] => 10690115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 872430 [patent_doc_number] => 07361663 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-22 [patent_title] => 'N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa' [patent_app_type] => utility [patent_app_number] => 10/686871 [patent_app_country] => US [patent_app_date] => 2003-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25516 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/361/07361663.pdf [firstpage_image] =>[orig_patent_app_number] => 10686871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1077037 [patent_doc_number] => 07615550 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists' [patent_app_type] => utility [patent_app_number] => 10/531758 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13530 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615550.pdf [firstpage_image] =>[orig_patent_app_number] => 10531758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378121 [patent_doc_number] => 20040220164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Triaza compound immunoregulatory agents' [patent_app_type] => new [patent_app_number] => 10/680076 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15243 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220164.pdf [firstpage_image] =>[orig_patent_app_number] => 10680076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656830 [patent_doc_number] => 20060142566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Enantioselective process for the preparation of both enantiomers of 10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide and new crystal forms thereof' [patent_app_type] => utility [patent_app_number] => 10/530617 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6706 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142566.pdf [firstpage_image] =>[orig_patent_app_number] => 10530617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 483141 [patent_doc_number] => 07220741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => '1,4-diazabicycloalkane derivatives, their preparation and use' [patent_app_type] => utility [patent_app_number] => 10/528361 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13568 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220741.pdf [firstpage_image] =>[orig_patent_app_number] => 10528361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677134 [patent_doc_number] => 20040152692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Pyrrolidine sulfonamides' [patent_app_type] => new [patent_app_number] => 10/472977 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5515 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152692.pdf [firstpage_image] =>[orig_patent_app_number] => 10472977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7427650 [patent_doc_number] => 20040229905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Preparation of risperidone' [patent_app_type] => new [patent_app_number] => 10/669272 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5007 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229905.pdf [firstpage_image] =>[orig_patent_app_number] => 10669272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7337067 [patent_doc_number] => 20040132723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Non-nucleoside reverse transcriptase inhibitors' [patent_app_type] => new [patent_app_number] => 10/662606 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10832 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132723.pdf [firstpage_image] =>[orig_patent_app_number] => 10662606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 383122 [patent_doc_number] => 07307074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-11 [patent_title] => 'Diazepan derivatives or salts thereof' [patent_app_type] => utility [patent_app_number] => 10/656129 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20108 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/307/07307074.pdf [firstpage_image] =>[orig_patent_app_number] => 10656129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474025 [patent_doc_number] => 20040097423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Platinum complexes as antitumor agents in combination with biochemical modulation' [patent_app_type] => new [patent_app_number] => 10/655657 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11097 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097423.pdf [firstpage_image] =>[orig_patent_app_number] => 10655657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 868679 [patent_doc_number] => 07365071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as β-lactamase inhibitors and antibacterials' [patent_app_type] => utility [patent_app_number] => 10/655364 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14985 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/365/07365071.pdf [firstpage_image] =>[orig_patent_app_number] => 10655364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474015 [patent_doc_number] => 20040121999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'CRF antagonistic pyrazolo[4,3-b]pyridines' [patent_app_type] => new [patent_app_number] => 10/650474 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11180 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121999.pdf [firstpage_image] =>[orig_patent_app_number] => 10650474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 494065 [patent_doc_number] => 07211574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-01 [patent_title] => 'Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders' [patent_app_type] => utility [patent_app_number] => 10/649495 [patent_app_country] => US [patent_app_date] => 2003-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12281 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211574.pdf [firstpage_image] =>[orig_patent_app_number] => 10649495 [rel_patent_id] =>[rel_patent_doc_number] =>)